A radioimmunological neutralization assay for the determination of hepatitis B e antibody is described. The method is compared with a blocking and a competitive assay and with immunodiffusion. The neutralization assay proved to be the most sensitive method, and results obtained by this method were reproduced most easily. The frequency of nonspecific results may be up to 1% of the sera tested. Among patients with acute type B hepatitis, e antibody was found regularly soon after the clearance of hepatitis B e antigen by using the neutralization assay, whereas this antibody was found on the average several weeks later and in a lower percentage of patients by using the other methods. It is concluded that at present the neutralization assay is the method of choice.
Since the discovery of the hepatitis B e antigen-antibody system in 1972 (6, 7) , this system has received increasing interest due to its obvious biological and clinical importance. However, the determination of hepatitis B e antigen (HBeAg) and antibody (anti-HBe) has been hampered by the relatively insensitive methods used but, recently, highly sensitive methods have been developed (2, 9) . By means of these tests, HBeAg is regularly found in acute type B hepatitis (1, 2, 5) , and the persistence of this antigen for more than 10 weeks after onset of symptoms indicates a chronic HB8Ag carrier state with high risk for development of chronic liver disease (1, 10) .
Previously, anti-HBe was only found regularly in asymptomatic healthy hepatitis B surface antigen (HB,Ag) carriers (4, 8) , and the presence of this antibody was associated with relatively low or non-infectivity of serum (3, 11) . Further, the presence of anti-HBe was considered to have some prognostic value in patients with chronic type B hepatitis. Therefore, sensitive and specific methods for the determination of this antibody seem important.
In the present study, a neutralization assay for the determination of anti-HBe is described and compared to three other methods for antiHBe determination. Sera from patients with acute type B hepatitis were used for evaluation.
MATERIALS AND METHODS
A total of 28 consecutive patients with biopsy-verified acute hepatitis and circulating HB.sAg in serum at the time of admittance to the hospital were included in the study. From 24 of these patients, weekly serum samples were available for the first 4 weeks after admittance, and from 27 patients serum samples were available from later follow-up examinations.
Further serum samples from 224 healthy staff members, all HB.Ag negative, were tested.
HB.Ag, anti-HB., and anti-HBc. HB.,Ag and antibody (anti-HR,) and antibody to the hepatitis B core antigen (anti-HB,) were determined by solid-phase radioimmunoassays (Ausria II, Ausab and Corab, Abbott Laboratories, North Chicago, Ill.).
HBAg. HBeAg was determined by a solid-phase radioimmunoassay (2) and by immunodiffusion (2) .
Anti-HBe. The following four methods were used. (i) Neutralization assay. For the neutralization assay, an HBeAg-positive serum of human origin was used as an HBeAg source. The HBeAg titer of this serum was between 1:800 and 1:1,600, determined by radioimmunoassay. For the anti-HBe determination, 100 1u of a predetermined dilution (1:150) of the HBeAg-positive serum was incubated overnight with 100 p1 of the serum to be tested. The amount of HBeAg in the initial incubation was selected to give specific binding of 5,000 to 10,000 cpm of '25I-labeled anti-HBe immunoglobulin G in the test when incubated with a serum negative for anti-HBe. After the first overnight incubation, an anti-HBe-coated bead was added to the mixture. After a second overnight incubation, the bead was washed and incubated overnight with 200 ,l of '25I-labeled anti-HB, immunoglobulin G preparation.
All incubations were carried out at room temperature. The bead was washed, and the bound radioactivity was counted. All serum samples that neutralized more than 50% of the predetermined quantity of HBWAg were considered positive for anti-HBe.
( (2) .
(iv) Immunodiffusion. Immunodiffusion was performed as previously described (2).
RESULTS
Sensitivity. Four anti-HBe-positive sera with different titers in immunodiffusion were selected for the comparison of methods. All tests were run in such a way that they were read on the same day, and the same ['251]anti-HBe label was used.
All dilutions were run in triplicates called A, B, and C. Endpoint titers of the four serum samples are shown in Table 1 . The endpoint titers are given as the last positive dilution before the first negative result was seen in the titration. In the blocking assay, it was sometimes observed that after the dilutions had become negative, they became positive again on further dilution and then finally negative. This phenomenon was only observed very seldom in the competition assay and never in the neutralization assay and may be due to a greater variation in the test reproducibility.
Generally, the neutralization test was the most sensitive method, followed by the blocking test, the competition test, and finally the immunodiffusion test. If the sensitivity of immunodiffusion was considered to be 1, the sensitivity of the competition test was about 10 times higher, that of the blocking test was about 150 times higher, detected by the neutralization test more frequently and much earlier in the course of the disease than it was by the blocking test. Among the remaining 4 of the 28 patients, 1 was followed for 3 weeks and was at that time anti-HBe positive only, by the neutralization assay. The other three patients were followed from 5 to 12 months. Of these, the first available serum sample from one patient had no HBe markers, whereas samples from the two others were antiHBe positive only by the neutralization test. In the last available serum sample, two patients were positive for anti-HBe by both the blocking and neutralization assay, whereas one was positive only by the neutralization assay.
DISCUSSION
In the clinical evaluation of patients with hepatitis B virus infections, the HBe system seems to be important due to its value in evaluation of infectivity and its probable prognostic value.
In the present report, three different radioimmunological methods and immunodiffusion were compared for the determination of anti-HBe. The neutralization assay was the most sensitive followed closely by the blocking test and then by the competitive test and immunodiffusion. Further, the neutralization assay was the most reproducible, showing maximally a twofold variation in the titers. The greater bead-to-bead variation found for the competition and blocking assays was probably due to the more difficult double coating of the beads (first with anti-HBe, then with HBeAg) used in these tests. Therefore, at present the neutralization assay seems to be the method of choice.
It has been reported previously that the neutralization assay is about 6,000 times more sensitive than rheophoresis (9) , an increase in sensitivity which was not found in this study when the neutralization procedure was compared to immunodiffusion. Among the 224 healthy staff members, 64 had circulating anti-HB5, anti-HBc, or both and, of these, 62.5% were found to be positive for antiHBe in the neutralization assay compared to 51.5% in the blocking assay. This difference is probably due to the difference in sensitivity between the two methods, as all persons except one positive by the blocking assay were also positive by the neutralization assay. Among four sera negative for other hepatitis B virus markers, two were positive for anti-HBe by the neutralization assay and two by the blocking assay. Whether these four sera were nonspecifically positive is not known. The frequency of nonspecific results obtained with each method could thus be as high as 1%.
Among patients with acute type B hepatitis, anti-HBe was found regularly soon after the clearance of HBeAg when the neutralization test was used. Using the blocking method, anti-HBe was demonstrable later and only in about onehalf of the patients. Previously, anti-HBe has been found in a varying number of patients with acute type B hepatitis (2, 10) , and this variation may not only be caused by a difference in sensitivity between the methods used but also by factors such as the avidity ofthe antibody, which may belong in part to the immunoglobulin M class.
In conclusion, we believe that the neutralization anti-HBe method is the method of choice until purified HBeAg and specific anti-HBe sera of animal origin become available.
